Nicotinamide Riboside for Skin: The NAD+ Precursor, Honestly Assessed
Nicotinamide riboside (NR) is a form of vitamin B3 sold as an NAD+-boosting longevity supplement, often under brand names like Tru Niagen. Of all the NAD+ precursors, it has the most human data behind one specific claim: that it raises blood NAD+. What it does not have is evidence for skin — and it is routinely, and wrongly, conflated with the niacinamide that has genuine topical skin evidence. Untangling those two is most of the value of this guide.
Quick Answer
Nicotinamide riboside is the best-studied NAD+ precursor for one thing: human trials consistently show it raises blood NAD+ by roughly 40–90% and is well tolerated (Martens et al., 2018). But raising NAD+ is a biomarker, not a skin outcome, and there is no robust controlled evidence that NR improves skin. Do not confuse NR with topical niacinamide (nicotinamide), which is a different molecule with real, direct skin evidence at 2–5%. NR is a reasonable longevity experiment; it is not a proven skin ingredient.
What Nicotinamide Riboside Is
Nicotinamide riboside is a vitamin B3 derivative and a precursor to NAD+, the coenzyme central to cellular energy and repair. NAD+ declines with age (McReynolds et al., 2020), and the longevity rationale for NR is straightforward: supply a raw material that lets cells rebuild NAD+. Among the NAD+ precursors, NR is the one with the clearest human pharmacology — several trials confirm that oral NR actually reaches the bloodstream and raises measurable NAD+ levels.
The Human Evidence: Strong on Biomarkers, Silent on Skin
The reference trial is Martens et al. (2018) in Nature Communications: a randomised, double-blind, placebo-controlled crossover study in 30 healthy middle-aged and older adults. Chronic NR at 500 mg twice daily raised blood NAD+ by roughly 60%, was well tolerated, and produced early signals toward lower blood pressure and arterial stiffness. Later trials extended this into specific conditions — for example a 2024 randomised trial in peripheral artery disease found a modest improvement in walking distance.
That is a genuinely solid biomarker story. But a careful published review of the field concluded that the actual clinical benefit of NR supplementation in humans remains to be established. And on skin specifically, there is essentially nothing: no controlled human trial demonstrating that oral NR improves wrinkles, elasticity, pigmentation, or barrier function. The skin rationale — better DNA repair, reduced UV-induced immunosuppression, mitochondrial support — is extrapolated from NAD+ biology, not shown in people.
The Niacinamide Confusion (This Is the Important Part)
The single biggest error around NR is conflating it with niacinamide. They are related B3 molecules but they are not interchangeable, and the evidence behind them could not be more different. Niacinamide (nicotinamide) applied topically at 2–5% has direct, repeatedly replicated skin evidence — for barrier support, pigmentation, and redness — and oral nicotinamide has trial evidence for reducing non-melanoma skin cancers in high-risk people. Nicotinamide riboside is a different, more expensive molecule sold for systemic NAD+ boosting, with no comparable skin evidence. If your goal is a skin benefit, the molecule with the evidence is topical niacinamide, not oral NR.
What Is Established vs. What Is Hype
| Claim | Evidence Strength | What the data shows | Status |
|---|---|---|---|
| NAD+ declines with age | Strong | Well documented in humans | Established biology |
| Oral NR raises blood NAD+ | Strong | Multiple human RCTs show a 40–90% rise; well tolerated | Well shown |
| NR improves cardiovascular / metabolic function | Emerging | Early signals on blood pressure and walking distance; not yet definitive | Preliminary |
| NR improves skin (wrinkles, elasticity, barrier) | Absent | No controlled human skin trials; do not confuse with topical niacinamide | Unproven |
How to Use It
Trials and products typically use 250 to 500 mg of NR per day, taken in the morning or midday. As with all supplements it is unregulated, so third-party testing is the meaningful quality marker. It is worth repeating that this is oral NR for systemic NAD+ — it is not a substitute for, and works nothing like, a topical niacinamide serum.
Who It Is For, and Who Should Be Cautious
Nicotinamide riboside suits adults exploring NAD+ and longevity supplementation, on the understanding that the well-established effect is a rise in a blood biomarker, not a proven clinical or cosmetic outcome. It has been well tolerated in trials but those trials are short; long-term safety is not established and there is no pregnancy or breastfeeding data, so it should be avoided there. Anyone wanting a skin benefit should reach for topical niacinamide, which has the evidence NR lacks. As always, NR does not replace sunscreen and a retinoid.
Pairs Well With / Avoid Combining
Commonly stacked with: Resveratrol, Coenzyme Q10. These are the compounds people combine Nicotinamide Riboside with in longevity stacks; the pairings are about a shared rationale, not a proven synergy for skin.
Avoid combining with: No adverse ingredient combinations are documented for this oral active in our catalogue. As an ingestible it does not conflict with topical actives, but supplement interactions with prescription medication are a separate question for a doctor or pharmacist.
Common Myths
"Nicotinamide riboside is niacinamide in a pill."
They are different molecules with completely different evidence bases. Topical niacinamide has direct skin evidence; NR is an oral NAD+ precursor with none for skin. This is the most important distinction in the whole category.
"NR raises NAD+, so it rejuvenates skin."
Raising blood NAD+ is well established. That it produces any visible skin change in humans is not — there are no controlled skin trials. A moved biomarker is not a demonstrated benefit.
"It is proven to slow ageing."
Human NR trials show biomarker and some early cardiovascular effects. A published review of the field explicitly concludes the clinical benefit remains to be understood. "Proven anti-ageing" overstates it.
Common Questions About Nicotinamide Riboside
Is nicotinamide riboside the same as niacinamide?
No, and this is the most common and consequential mix-up in the supplement aisle. Niacinamide (nicotinamide) is the B3 form with strong, direct skin evidence — topically at 2–5% for barrier, pigmentation and redness, and orally for skin-cancer risk reduction in high-risk people. Nicotinamide riboside is a different, pricier molecule marketed for raising systemic NAD+, and it has no comparable skin evidence. If you want a skin result, the molecule with the data is topical niacinamide.
Does nicotinamide riboside raise NAD+?
Yes — this is the one claim NR has strong human evidence for. Randomised controlled trials show oral NR reliably raises blood NAD+ by roughly 40 to 90% and is well tolerated over the study periods. The open question is not whether it raises NAD+ but whether that translates into meaningful clinical or cosmetic benefits, which current evidence does not yet establish.
Will nicotinamide riboside improve my skin?
There is no robust controlled human trial showing that oral NR improves skin. The rationale — supporting DNA repair and mitochondrial function through higher NAD+ — is biologically reasonable but unproven in people. For an evidence-backed skin benefit, topical niacinamide is the appropriate choice; NR is better understood as a systemic longevity experiment.
References
- Martens CR, et al. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications.
- McReynolds MR, Chellappa K, Baur JA. (2020). Age-related NAD+ decline. Experimental Gerontology.
- Covarrubias AJ, et al. (2021). NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology.
Skin Stacker is independent: no ads, no affiliate links, no paid placement. We have no supplement to sell you and no commercial reason to overstate the evidence — which is exactly why the assessment above stays honest about how thin the human skin data is. Reviewed / Last updated: 18 July 2026 · by JoAnn.